24 okt: Schering: Undersøgelsesresultat vedr. tidlig MS offentlig...
24 okt: Fabricius og Kastholms møbelklassikere
24-10-2006 11:39:00

Hugin Ad hoc announcement according to § 15 WpHG: Misc. business figure: STRATEC Biomedical Systems AG: STRATEC clearly exceeds earnings for overall previous year after only nine months

Birkenfeld, October 24, 2006

The Board of Management of STRATEC Biomedical Systems AG, which is

listed in the Prime Standard and Gate-M indices, hereby announces the

preliminary, unaudited consolidated figures based on IFRS

(International Financial Reporting Standards) of the STRATEC Group

for the first nine months of the 2006 financial year pursuant to

Section 15 of the German Securities Trading Act (WpHG).

+-------------------------------------------------------------------+

| Key Figures (EUR | 01.01.- | 01.01.- | Change |

| 000s) | 09.30.2006 | 09.30.2005 | |

|---------------------+-----------------+-----------------+---------|

| Sales | 51,933 | 33,945 | + 53.0% |

|---------------------+-----------------+-----------------+---------|

| Gross performance | 51,887 | 35,582 | + 45.8% |

|---------------------+-----------------+-----------------+---------|

| EBITDA | 8,295 | 5,315 | + 56.1% |

|---------------------+-----------------+-----------------+---------|

| EBIT | 7,199 | 4,587 | + 56.9% |

|---------------------+-----------------+-----------------+---------|

| EBT | 7,097 | 4,409 | + 61.0% |

|---------------------+-----------------+-----------------+---------|

| Consolidated net | 5,304 | 2,895 | + 83.2% |

| income | | | |

|---------------------+-----------------+-----------------+---------|

| Earnings per share | 0.48 | 0.29 | + 65.5% |

| (EUR) | | | |

+-------------------------------------------------------------------+

The STRATEC Group had a total of 215 employees as of

September 30, 2006 (previous year: 189).

Information and disclosures concerning this ad-hoc announcement:

Irrespective of possible new levels of sales and earnings correlating

with the market launch of new analyzer system families, the company

assumes that the seasonal fluctuations witnessed in sales and

earnings in the past will be increasingly countered by logistical

measures involving procurement and production.

In the past 2005 financial year, the STRATEC Group had an average of

191 employees and generated sales of Euro 47.3 million, earnings

before tax (EBT) of Euro 6.9 million and consolidated income of Euro

4.4 million, with earnings per share of Euro 0.43 (earnings for

overall previous year).

The extensive interim report will be available on our internet page

as a download from around 3 p.m. on November 8, 2006.

Based on current budgeting, the growth forecast for the company will

be reflected in particular from the second and third quarter of the

2007 financial year onwards.

About STRATEC

STRATEC Biomedical Systems AG (http://www.stratec-biomedical.de)

designs and manufactures fully automated systems for its partners in

the fields of clinical diagnostics and biotechnology. These partners

market such systems, in general together with their own reagents, to

laboratories and research institutes around the world. The company

develops its products on the basis of its own patented technologies.

Shares in the company (SIN: 728900 / ISIN: DE0007289001) are traded

in the Prime Standard segment of the Frankfurt Stock Exchange, in the

Gate-M trading segment of the Stuttgart Stock Exchange and on other

exchanges.

The STRATEC Group comprises the listed holding company "STRATEC

Biomedical Systems AG", as well as the subsidiaries "STRATEC NewGen",

"Robion" and "Sanguin".

Further information can be obtained from:

STRATEC Biomedical Systems AG

André Loy, Investor Relations

Gewerbestrasse 37, 75217 Birkenfeld

Germany

Tel: +49 7082 7916-190

Fax: +49 7082 7916-999

E-Mail: ir@stratec-biomedical.de

--- End of Ad-hoc Message ---

WKN: 728900; ISIN: DE0007289001;

Listed: Geregelter Markt in Frankfurter Wertpapierbörse, Gate-M in

Börse Stuttgart,

Freiverkehr in Börse Berlin Bremen, Freiverkehr in Bayerische Börse

München,

Freiverkehr in Börse Düsseldorf;

Copyright © Hugin ASA . All rights reserved.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
21 aug
VELO
Kære debatdeltagere   Det har gjort et meget stort indtryk på mig, at så mange har læst og sat pris ..
35
20 aug
BIOPOR
  Bioporto kom med Q2 regnskab fredag den 8/8, og holdt efterfølgende en investor præsentation. Jeg ..
29
19 aug
VELO
Som overskriften så pænt fortæller, så vil jeg gerne have Match tilbage. Og fordi at jeg tør og skri..
29
21 aug
VELO
Hej Westphal   Ja - og en audiocast ligger tilgængelig på Veloxis' hjemmeside: http://www.media-serv..
27
19 aug
VELO
Jeg har rejst en del denne sommer, me har ind imellem lige været inde for at se, om der er nyt. Sene..
23
17 aug
 
Janemlig, jeg synes det er forstemmende man kan leve med fri adgang til alle informationer og så all..
17
20 aug
VWS
Tadaaa! Tillykke d'herrer. Det er en stor dag i Euroinvestors Vestas forum. Det her må være først..
15
18 aug
 
  Financial Times har i dag bragt en ganske interessant artikel. Federal Reserve har d. 5. August i ..
15
08:45
VWS
Jeg har meget ofte set en meget misforstået opdeling af hvordan MHI vestas ordre kommer til at påvir..
14
20 aug
VWS
Gud bedre det!   Vestas har en brutto margin på over 19 % og har lavet en opjustering som endda ser ..
12

Vestas: Kinesisk rival tredobler indtjeningen

22-08-2014 15:25:46
Vestas' kinesiske konkurrent Xinjiang Goldwind Science havde markant vækst i såvel omsætning som indtjening i første halvår.Resultatet efter skat blev mere end ..

DFDS suspenderer nyligt åbnet rute i Østersøen

22-08-2014 14:34:54
DFDS suspenderer ruten mellem Tyskland og Lituaen på baggrund af de geopolitiske spændinger mellem Rusland og Vesten.Det meddeler DFDS i en selskabsmeddelelse f..

Vestas-rival overvejer japansk offshorepartner - bureau

22-08-2014 09:30:02
Vestas kommer måske ikke til at være den eneste vindmølleproducent med en japansk partner på offshoreområdet.Indiske Suzlon Energy, og det tyske datterselskab S..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
Euroinvestor i andre lande: Euroinvestor.com | Euroinvestor.se | Euroinvestor.no | Euroinvestor.fr | Forexinvestor.com| Wisselkoersen.nl | Valuta.se | Valutaveksel.no | Divisas.es | Valute.it
Copyright Euroinvestor A/S 2014  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
23. august 2014 21:49:34
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20140819.1 - EUROWEB7 - 2014-08-23 21:49:34 - 2014-08-23 21:49:34 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x